238 related articles for article (PubMed ID: 37122538)
1. Recent developments of imidazo[1,2-
Samanta S; Kumar S; Aratikatla EK; Ghorpade SR; Singh V
RSC Med Chem; 2023 Apr; 14(4):644-657. PubMed ID: 37122538
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis Drug Discovery: Challenges and New Horizons.
Fernandes GFS; Thompson AM; Castagnolo D; Denny WA; Dos Santos JL
J Med Chem; 2022 Jun; 65(11):7489-7531. PubMed ID: 35612311
[TBL] [Abstract][Full Text] [Related]
4. Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents.
Bvumbi MV
ChemMedChem; 2020 Dec; 15(23):2207-2219. PubMed ID: 32844566
[TBL] [Abstract][Full Text] [Related]
5. Telacebec (Q203): Is there a novel effective and safe anti-tuberculosis drug on the horizon?
Malík I; Čižmárik J; Kováč G; Pecháčová M; Hudecova L
Ceska Slov Farm; 2021; 70(5):164–171. PubMed ID: 34875838
[TBL] [Abstract][Full Text] [Related]
6. Telacebec (Q203): Is there a novel effective and safe anti-tuberculosis drug on the horizon?
Malík I; Čižmárik J; Kováč G; Pecháčová M; Hudecova L
Ceska Slov Farm; 2021; 70(5):164-171. PubMed ID: 35114793
[TBL] [Abstract][Full Text] [Related]
7. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
[TBL] [Abstract][Full Text] [Related]
8. Overview of drug-resistant tuberculosis worldwide.
Velayati AA; Farnia P; Farahbod AM
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S161. PubMed ID: 28043527
[TBL] [Abstract][Full Text] [Related]
9. Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.
Fernandes GFDS; Man Chin C; Dos Santos JL
Pharmaceuticals (Basel); 2017 Jun; 10(2):. PubMed ID: 28587160
[TBL] [Abstract][Full Text] [Related]
10. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
Moraski GC; Oliver AG; Markley LD; Cho S; Franzblau SG; Miller MJ
Bioorg Med Chem Lett; 2014 Aug; 24(15):3493-8. PubMed ID: 24909079
[TBL] [Abstract][Full Text] [Related]
11. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
Prasad R
Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
[TBL] [Abstract][Full Text] [Related]
12. BacPROTACs targeting Clp protease: a promising strategy for anti-mycobacterial drug discovery.
Bonjorno AF; Pavan AR; Fernandes GFS; Scarim CB; Castagnolo D; Dos Santos JL
Front Chem; 2024; 12():1358539. PubMed ID: 38357296
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
[TBL] [Abstract][Full Text] [Related]
14. Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and "Anagrams" Generated Potent Antituberculosis Agents.
Moraski GC; Miller PA; Bailey MA; Ollinger J; Parish T; Boshoff HI; Cho S; Anderson JR; Mulugeta S; Franzblau SG; Miller MJ
ACS Infect Dis; 2015 Feb; 1(2):85-90. PubMed ID: 25984566
[TBL] [Abstract][Full Text] [Related]
15. Management of drug resistantTB in patients with HIV co-infection.
Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
[TBL] [Abstract][Full Text] [Related]
16. [Drug resistant tuberculosis].
Zwolska Z; Augustynowicz-Kopeć E
Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
[TBL] [Abstract][Full Text] [Related]
17. The resumption of consumption -- a review on tuberculosis.
Ducati RG; Ruffino-Netto A; Basso LA; Santos DS
Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):697-714. PubMed ID: 17160276
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistant tuberculosis: past, present, future.
Chiang CY; Centis R; Migliori GB
Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
[TBL] [Abstract][Full Text] [Related]
19. A cross-sectional study about knowledge and attitudes toward multidrug-resistant and extensively drug-resistant tuberculosis in a high-burden drug-resistant country.
Javed H; Tahir Z; Hashmi HJ; Jamil N
Int J Mycobacteriol; 2016 Jun; 5(2):128-34. PubMed ID: 27242222
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
